دوره 10، شماره 1 - ( 3-1402 )
جلد 10 شماره 1 صفحات 44-39 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahpeyma M, Khosravy M S. Rabies vaccine: progress and prospective. vacres 2023; 10 (1) :39-44
URL: http://vacres.pasteur.ac.ir/article-1-339-fa.html
URL: http://vacres.pasteur.ac.ir/article-1-339-fa.html
Rabies vaccine: progress and prospective. Vaccine Research. 1402; 10 (1) :39-44
چکیده: (333 مشاهده)
Rabies is a zoonotic disease, endemic mostly in Asia and Africa. Rabies virus belongs to the family Rhabdoviridae, genus Lyssavirus. Because infection with rabies virus has no cure and is life-threatening, vaccination is an important preventive measure to combat this disease in humans and animals. On the other hand, considering the limited availability of rabies vaccines in some of less developed countries with a higher rate of human rabies death each year, the need for an alternative strategy to produce a cost-effective and immunogenic vaccine against this disease is essential. In this review, we provide a brief overview of rabies vaccine development and its recent basic research. We also describe how viral vectors such as poxvirus vector, adenovirus replicons, and reverse genetics are manipulated for efficient novel formulated vaccines against this infection and we highlight possible future developments
نوع مطالعه: Review article |
موضوع مقاله:
Vaccine development, efficacy and safety evaluation
دریافت: 1402/12/22
دریافت: 1402/12/22
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.